TWD 21.0
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 141.16 Million TWD | -13.75% |
2022 | 163.66 Million TWD | -0.57% |
2021 | 164.6 Million TWD | -25.62% |
2020 | 221.29 Million TWD | -2.51% |
2019 | 226.98 Million TWD | 115.76% |
2018 | 105.2 Million TWD | -63.79% |
2017 | 290.52 Million TWD | 1.8% |
2016 | 285.39 Million TWD | 0.0% |
2015 | - TWD | 0.0% |
2014 | - TWD | 0.0% |
2013 | - TWD | 0.0% |
2012 | - TWD | 0.0% |
2011 | - TWD | 0.0% |
2010 | - TWD | -100.0% |
2009 | 46.76 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 136.85 Million TWD | -0.86% |
2024 Q2 | 110.72 Million TWD | -1.14% |
2023 Q3 | 147.01 Million TWD | -3.47% |
2023 Q1 | 156.79 Million TWD | -4.2% |
2023 FY | 141.16 Million TWD | -13.75% |
2023 Q4 | 141.16 Million TWD | -3.98% |
2023 Q2 | 152.3 Million TWD | -2.86% |
2022 Q3 | 154.99 Million TWD | -2.94% |
2022 FY | 163.66 Million TWD | -0.57% |
2022 Q4 | 163.66 Million TWD | 5.6% |
2022 Q1 | 162.48 Million TWD | -1.29% |
2022 Q2 | 159.68 Million TWD | -1.72% |
2021 FY | 164.6 Million TWD | -25.62% |
2021 Q3 | 189.98 Million TWD | -5.82% |
2021 Q4 | 164.6 Million TWD | -13.36% |
2021 Q1 | 207.49 Million TWD | -6.24% |
2021 Q2 | 201.73 Million TWD | -2.77% |
2020 Q2 | 207.79 Million TWD | -4.54% |
2020 FY | 221.29 Million TWD | -2.51% |
2020 Q3 | 219.96 Million TWD | 5.86% |
2020 Q4 | 221.29 Million TWD | 0.6% |
2020 Q1 | 217.67 Million TWD | -4.1% |
2019 Q1 | 190.27 Million TWD | 80.86% |
2019 Q3 | 173.35 Million TWD | -6.69% |
2019 Q4 | 226.98 Million TWD | 30.94% |
2019 FY | 226.98 Million TWD | 115.76% |
2019 Q2 | 185.78 Million TWD | -2.36% |
2018 Q2 | 293.1 Million TWD | 0.45% |
2018 Q3 | 294.42 Million TWD | 0.45% |
2018 Q4 | 105.2 Million TWD | -64.27% |
2018 Q1 | 291.8 Million TWD | 0.44% |
2018 FY | 105.2 Million TWD | -63.79% |
2017 Q1 | 286.65 Million TWD | 0.44% |
2017 FY | 290.52 Million TWD | 1.8% |
2017 Q4 | 290.52 Million TWD | 0.45% |
2017 Q3 | 289.22 Million TWD | 0.45% |
2017 Q2 | 287.93 Million TWD | 0.45% |
2016 Q2 | - TWD | 0.0% |
2016 Q3 | - TWD | 0.0% |
2016 Q4 | 285.39 Million TWD | 0.0% |
2016 Q1 | - TWD | 0.0% |
2016 FY | 285.39 Million TWD | 0.0% |
2015 FY | - TWD | 0.0% |
2015 Q4 | - TWD | 0.0% |
2015 Q3 | - TWD | 0.0% |
2015 Q1 | - TWD | 0.0% |
2015 Q2 | - TWD | 0.0% |
2014 Q2 | - TWD | 0.0% |
2014 FY | - TWD | 0.0% |
2014 Q1 | - TWD | 0.0% |
2014 Q3 | - TWD | 0.0% |
2014 Q4 | - TWD | 0.0% |
2013 Q1 | - TWD | 0.0% |
2013 FY | - TWD | 0.0% |
2013 Q4 | - TWD | 0.0% |
2013 Q3 | - TWD | 0.0% |
2013 Q2 | - TWD | 0.0% |
2012 Q1 | - TWD | 0.0% |
2012 FY | - TWD | 0.0% |
2012 Q4 | - TWD | 0.0% |
2012 Q3 | - TWD | 0.0% |
2012 Q2 | - TWD | 0.0% |
2011 Q2 | - TWD | 0.0% |
2011 FY | - TWD | 0.0% |
2011 Q1 | - TWD | 0.0% |
2011 Q3 | - TWD | 0.0% |
2011 Q4 | - TWD | 0.0% |
2010 FY | - TWD | -100.0% |
2010 Q4 | - TWD | 0.0% |
2009 FY | 46.76 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Excelsior Medical Co., Ltd. | 236.82 Million TWD | 40.393% |
OK Biotech Co., Ltd. | 94.1 Million TWD | -50.006% |
Applied BioCode Corporation | 18.07 Million TWD | -680.872% |